Page 6 - Laboratory Network News Today

COVID-19 research Contact We’re involved in a broad range of activities with government and industry in response to COVID-19, including preclinical testing of potential vaccines, understanding the virus and its mutations, monitoring wastewater, supporting manufacturing of surgical masks, and analysing and sharing trends in data and the impact on health services. This is part of our efforts to future-proof Australia against the impacts of future pandemics, supporting nationa...

ANALYSIS: One year after, five gaps in Nigeria’s management of COVID-19 Nigeria recorded its first case of COVID-19 a year ago. 7 min read It is exactly 12 months since medics were summoned to what became the first confirmed case of COVID-19 in Nigeria. Since then, over 155,000 infections have led to more than 1,900 deaths. While Nigeria, like most African countries, has not suffered from the worst effect of the pandemic, unlike its European and American counterparts, the Nige...

Empowering Laboratory Professionals on Quality Management Systems during the Training of Trainers Format Port Louis - Thirty-two laboratory professionals responsible in the establishment and implementation of Quality Management System (QMS) have been trained during a five-day training workshop prior to the implementation of the Laboratory Quality Management System (LQMS) in Mauritius. The training of trainers aimed at building capacity of diagnostics laboratories and improve quality diagnostic ...

For consideration of Rs 511 croreMetropolis Healthcare announced that the Board of Directors has approved the acquisition of Dr. Ganesans Hitech Diagnostic Centre (Hitech). The acquisition will be a combination of cash and stock deal. The target entity is a debt free company. Cash consideration will be Rs. 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs.2/- each on preferential basis, subject to Shareholders approval, to the Promoter Group of Hitech. The Cash ...

Metropolis Healthcare announced that the board of directors has approved the acquisition of Dr. Ganesans Hitech Diagnostic Centre (Hitech). Established in 1986, Hitech Diagnostic Centre is a diagnostics laboratory chain in the South India market. Metropolis will acquire 100% equity of Dr. Ganesans Hitech Diagnostic Centre in a combination of cash and stock deal. The entity is a debt free company. This acquisition is expected to be completed within 3 months. Cash consideration will be Rs. 511 c...

Albania: Privatisation of hospital lab services has negatively impacted Covid-19 research and response, critics say Canva Albanian Doctors Fret over Private Control of Hospital Labs, 5 January 2021 A 2019 government deal with a private venture to improve lab services in Albania ended up complicating efforts to expand COVID-19 testing, critics say, and is causing concern over the long-term impact on publicly-funded diagnostics and scientific research. Since November, when administration of the i...

Head of Department, Surveillance and Epidemiology, Elsie Ilori Photo: Twitter The number of confirmed coronavirus cases in Nigeria surpassed 100,000 on Jan.10 after 1,024 new cases were reported, bringing the total number of infections to 100,087. The Nigeria Centre for Disease Control (NCDC) disclosed on its verified website on Sunday. The NCDC regrettably reported eight additional COVID-19-related deaths in the last 24 hours in the country. x The agency sai...

The public health agency said that the country’s active cases were 18,699, while only two states, Kogi and Cross River, had no active case of the infection as at Jan. 10.

As the year 2020 gradually comes to an end, Onyebuchi Ezigbo captures some of the key events that shaped this highly eventful and turbulent year, especially in the health sector The year, 2020 will no doubt go down in world history as one of the most remarkable in recent times. It is a year that challenged every of mankind’s ingenuinety and technological prowers. It is a year that the whole world was literally brought to its kneels by a novel virus named COVID-19, which has remained incurabl...

Share this article Share this article NASHVILLE, Tenn., Dec. 21, 2020 /PRNewswire/ -- Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically appropriate genetic testing while improving payment integrity and reducing manual work. This solution comes as the volume of genetic testing continues to rise, and as biomarkers increasingly influence clinica...